News
RIBOPRO Secures €1.9 Million in Convertible Loan, Accelerating Progress in mRNA Technology and Series A Funding
Oss, Netherlands, January 10, 2024 — RIBOPRO, a leading biotechnology company specializing in supporting biotech and bio-pharma through the co-creation of innovative mRNA drugs based on patented mRNA technologies and high-quality mRNA/LNP producti
NutriLeads Completes 4.5 Million Euro Series C Financing to Accelerate Commercialization of BeniCaros as a Global Precision Prebiotic Brand
Company also announces Board and Management changes and new scientific advisory board December 18, 2023 – NutriLeads BV today announced that it has raised 4.5 million euros in a Series C investment round to accelerate the commercializatio
Predica Diagnostics wins Investor Forum
Today, at the Dutch Life Sciences Conference in Corpus, Venture Challenge alumnus Predica Diagnostics was selected winner of the Investor Forum.
XS-Innovations wins Venture Challenge Fall 2023!
The winner of the Venture Challenge was announced today at the Dutch Life Sciences Conference. The proud winner of the 2023 fall edition is
€1.4 million for the acceleration of VivArt-X research
Venture Challenge alumnus VivArt-X will collaborate with Smart BioMaterials Consortium (SBMC) and
Venture Challenge Spring 2023 winner Exculture has successfully secured €350,000 in financing from UNIIQ/Delft Enterprises.
ExCulture is working on the development of a fermentation process that has the potential to provide a safer way of producing heparin on a larger scale.
Sirius Medical Ranked Most Innovative Dutch Healthcare SME by the Chamber of Commerce
Eindhoven, Netherlands – December 1, 2023 – Venture Challenge alumnus Sirius Medical, a leader in Surgical Marker Navigation, has been recognized as the most innovative Healthcare SME in The Netherlands, according to the prestigious Chamber
VivArt-X raises 660k€ pre-seed round
Venture Challenge alumnus VivArt-X has closed a pre-seed round of €660,000 to accelerate and further develop a proof-of-concept.
These are the Venture Challenge Fall 2023 teams!
Six teams have started the Venture Challenge Fall 2023! Between 11 October and 7 December these starting lifesciences entrepreneurs will learn everything there is to know about building and pitching a businessplan.
Scope Biosciences raises 500k€ investment from SHIFT and Oost NL
WAGENINGEN, October 23rd 2023 – Scope Biosciences B.V., a pioneer in CRISPR-Cas based molecular diagnostics and Venture Challenge Alumnus of 2020, announces a €500K investment round led by SHIFT Invest’s TTT fund and Oost NL.